The Clinical Observation of Combination of Calcipotriol and Halometasone in the Treatment of Plaque Psoriasis
Zhongwei Tian
Abstract
Zhongwei Tian
Abstract
Objective To investigate the clinical efficacy and safety of the combination of calcipotriol and halometasone in the treatment of plaque psoriasis.Methods One hundred and twenty patients were divided into three groups.Treatment group used calcipotriol once in the morning and halometasone once in evening.The control groupⅠonly used calcipotriol twice a day.The control groupⅡonly used halometasone twice a day. Four weeks later compared the effectiveness of each group.Results The efficiency of treatment group (81.58%) was significantly higher than that in calcipotriol group(62.86%) and halometasone group (60.00%) after 4 weeks(P0.05).Safety date showed the frequency of adverse events in the treatment group was low.Conclusion The sequential therapy of calcipotriol and halometasone is effective and safe.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the clinical efficacy and safety of the combination of calcipotriol and halometasone in the treatment of plaque psoriasis.Methods One hundred and twenty patients were divided into three groups.Treatment group used calcipotriol once in the morning and halometasone once in evening.The control groupⅠonly used calcipotriol twice a day.The control groupⅡonly used halometasone twice a day. Four weeks later compared the effectiveness of each group.Results The efficiency of treatment group (81.58%) was significantly higher than that in calcipotriol group(62.86%) and halometasone group (60.00%) after 4 weeks(P0.05).Safety date showed the frequency of adverse events in the treatment group was low.Conclusion The sequential therapy of calcipotriol and halometasone is effective and safe.
Key concepts: Calcipotriol, Medicine, Dermatology, Adverse effect, Psoriasis, Evening, Internal medicine, Physics